Introduction: aclass="ed_image_link"title=""href="/ugc/baikepic2/12495/20160726125021-347555147.jpg/800"target="_blank"gt; Created by Fuzhou Chenxing Pharmaceutical Co., Ltd. Founded in 1993, it is a Hong Kong-owned enterprise integrating R&D, production and sales. Fuzhou Chenxing Pharmaceutical Co., Ltd. has strong modern pharmaceutical enterprise management capabilities and new product research and development capabilities. Fuzhou Chenxing Pharmaceutical Co., Ltd. has embarked on a high-speed development path to build an economic zone on the west coast of the Taiwan Strait. Fuzhou Chenxing Pharmaceutical Co., Ltd. is located in Jinshan Industrial Zone, Fuzhou City, the provincial capital, on the banks of the beautiful Minjiang River. It covers an area of ??15,010.3 square meters and has a construction area of ??5,613.34 square meters. It has greening, employee swimming pools, rest corridors and other facilities. It is a garden-style enterprise with an elegant environment. In 2003, the company invested more than 20 million yuan in GMP transformation and passed GMP certification in 2004. The company currently has three GMP production lines for capsules, tablets and granules, with annual production capacities of 1 billion capsules, 500 million tablets and 50 million bags respectively. Fuzhou Chenxing Pharmaceutical Co., Ltd. currently has 110 employees, including 48 professional and technical personnel. College degree or above accounted for 60%. The company adheres to the corporate governance strategy of "people-oriented, morality first, sincerity, and trust first", forming a sound operating situation that is market-oriented, relying on high technology, and guaranteed by modern management, and strives to build a corporate brand, and the company The trademark "Luo Xing" has been rated as a well-known trademark in Fuzhou for two consecutive years. Fuzhou Chenxing Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise that mainly produces Chinese and Western medicine preparations and integrates scientific research, production and marketing. Three major series and more than ten varieties, the products have high technological content and strong characteristics. Among them, Luoxing brand "Shu Mi Capsules" and "Compound Dibazole Hydrochlorothiazide Capsules" (formerly used: compound antihypertensive capsules) are the company's flagship products. Ten years of quality assurance, ten years of market share, and ten years of after-sales service prove the vitality of these two varieties. However, the company is not complacent. While production and sales are booming, it sees potential crises and stores, develops and develops a batch of new products, laying a solid foundation for the company's healthy development. The "Xieding Capsule" developed by the company is a protected variety of traditional Chinese medicine and is exclusive nationwide. It is the only specific medicine for the treatment of rotavirus infection (such as diarrhea in children with a high incidence rate in autumn and winter).
Legal representative: Chen Li
Establishment date: 1993-08-10
Registered capital: 10 million yuan
Industrial and commercial registration No.: 350105400000169
Enterprise type: Limited liability company (sole proprietorship by legal persons from Taiwan, Hong Kong and Macao)
Company address: Building 5, Changtian Industrial Park, Changsheng Road 2, Chang'an Investment Zone, Fuzhou Development Zone South side of the east side of the second-floor industrial factory (within the Free Trade Pilot Zone)